A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants
Clinical trial NCT01762839 · COMPLETED
Trial details
- NCT number
- NCT01762839
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-27
- Primary completion
- 2013-01-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.